{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:13:11Z","timestamp":1793531591957,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>More than 95% of patients fall victim to primary amoebic meningoencephalitis (PAM), a fatal disease attacking the central nervous system. <jats:italic>Naegleria fowleri<\/jats:italic>, a brain-eating microorganism, is PAM's most well-known pathogenic ameboflagellate. Despite the use of antibiotics, the fatality rate continues to rise as no clinical trials have been conducted against this disease. To address this, we mined the UniProt database for pathogenic proteins and selected assumed epitopes to create an mRNA-based vaccine. We identified thirty B-cell and T-cell epitopes for the vaccine candidate. These epitopes, secretion boosters, subcellular trafficking structures, and linkers were used to construct the vaccine candidate. Through predictive modeling and confirmation via the Ramachandran plot (with a quality factor of 92.22), we assessed secondary and 3D structures. The adjuvant RpfE was incorporated to enhance the vaccine construct's immunogenicity (GRAVY index: 0.394, instability index: 38.99, antigenicity: 0.8). The theoretical model of immunological simulations indicated favorable responses from both innate and adaptive immune cells, with memory cells expected to remain active for up to 350\u00a0days post-vaccination, while the antigen was eliminated from the body within 24\u00a0h. Notably, strong interactions were observed between the vaccine construct and TLR-4 (\u2212 11.9\u00a0kcal\/mol) and TLR-3 (\u2212 18.2\u00a0kcal\/mol).<\/jats:p>","DOI":"10.1038\/s41598-023-51127-8","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T11:02:36Z","timestamp":1704711756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Development and immunological evaluation of an mRNA-based vaccine targeting Naegleria fowleri for the treatment of primary amoebic meningoencephalitis"],"prefix":"10.1038","volume":"14","author":[{"given":"Muhammad","family":"Naveed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urooj","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khizra","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hammad","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metab","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah F.","family":"Alasmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamer H.","family":"Albekairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"51127_CR1","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.meegid.2011.07.023","volume":"11","author":"JF De Jonckheere","year":"2011","unstructured":"De Jonckheere, J. F. Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleri. Infect. Genet. Evol. 11, 1520\u20131528. https:\/\/doi.org\/10.1016\/j.meegid.2011.07.023 (2011).","journal-title":"Infect. Genet. Evol."},{"key":"51127_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13192","author":"M Jahangeer","year":"2019","unstructured":"Jahangeer, M. et al. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review. Clin. Exp. Pharmacol. Physiol. https:\/\/doi.org\/10.1111\/1440-1681.13192 (2019).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"51127_CR3","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1093\/cid\/ciaa520","volume":"73","author":"R Gharpure","year":"2021","unstructured":"Gharpure, R. et al. Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri: A global review. Clin. Infect. Dis 73, e19\u2013e27. https:\/\/doi.org\/10.1093\/cid\/ciaa520 (2021).","journal-title":"Clin. Infect. Dis"},{"issue":"51","key":"51127_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1574-695x.2007.00332.x","volume":"2007","author":"F Marciano-Cabral","year":"2007","unstructured":"Marciano-Cabral, F. & Cabral, G. A. The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Microbiol. Immunol. 2007(51), 243\u2013259. https:\/\/doi.org\/10.1111\/j.1574-695x.2007.00332.x (2007).","journal-title":"FEMS Microbiol. Immunol."},{"key":"51127_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2019.10.008","author":"SK Maciver","year":"2019","unstructured":"Maciver, S. K., Pi\u00f1ero, J. E. & Lorenzo-Morales, J. Is Naegleria fowleri an emerging parasite?. Trends Parasitol. https:\/\/doi.org\/10.1016\/j.pt.2019.10.008 (2019).","journal-title":"Trends Parasitol."},{"key":"51127_CR6","unstructured":"CDC (2022). Case Report Data & Graphs | Naegleria fowleri|CDC. www.cdc.gov. https:\/\/www.cdc.gov\/parasites\/naegleria\/graphs.html. Accessed 29 June 2023."},{"key":"51127_CR7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13698","author":"A Alli","year":"2021","unstructured":"Alli, A., Ortiz, J. F., Morillo Cox, \u00c1., Armas, M. & Orellana, V. A. Miltefosine: A miracle drug for meningoencephalitis caused by free-living amoebas. Cureus https:\/\/doi.org\/10.7759\/cureus.13698 (2021).","journal-title":"Cureus"},{"key":"51127_CR8","unstructured":"World Health Organization. Statement on miltefosine\u2014Potential ocular disorders in patients treated with miltefosine for post-kala-azar dermal leishmaniasis (PKDL). www.who.int. https:\/\/www.who.int\/news\/item\/10-02-2022-statement-on-miltefosine-potential-ocular-disorders-in-patients-treated-with-miltefosine-for-post-kala-azar-dermal-leishmaniasis-(pkdl). Accessed 26 June 2023 (2022)."},{"key":"51127_CR9","unstructured":"Breen, K. Case of \"brain-eating amoeba\" reported in Florida, possibly linked to sinus rinse with tap water. CBS News. https:\/\/www.cbsnews.com\/news\/brain-eating-amoeba-florida-sinus-rinse-tap-water-charlotte-county\/. Accessed 29 June 2023 (2023)."},{"key":"51127_CR10","unstructured":"The Express Tribune. Naegleria fowleri poses serious health threats. The Express Tribune. https:\/\/tribune.com.pk\/story\/2419460\/naegleria-fowleri-poses-serious-health-threats. Accessed 30 July 2023 (2023)."},{"key":"51127_CR11","unstructured":"Upadhyay, A. Kerala boy dies due to brain-eating amoeba: What's it all about and how can it infect you? The Indian Express. https:\/\/indianexpress.com\/article\/health-wellness\/kerala-boy-dies-brain-eating-amoeba-what-how-8809693\/. Accessed 1 Aug 2023 (2023)."},{"key":"51127_CR12","unstructured":"Gilani, I. Lahore reports first death by Naegleria. Pakistan Observer. https:\/\/pakobserver.net\/lahore-reports-first-death-by-naegleria\/. Accessed 1 Aug 2023 (2023)."},{"key":"51127_CR13","unstructured":"Centers for Disease Control and Prevention. Primary Amebic Meningoencephalitis (PAM)-Naegleria fowleri. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/parasites\/naegleria\/index.html. Accessed 29 June 2023 (2019)."},{"key":"51127_CR14","unstructured":"Centers for Disease Control and Prevention. Prevention & Control|Naegleria fowleri|CDC. www.cdc.gov. https:\/\/www.cdc.gov\/parasites\/naegleria\/prevention.html. Accessed 28 June 2023 (2019)."},{"key":"51127_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1098217","author":"T Saleem","year":"2023","unstructured":"Saleem, T. et al. In-silico drug design for the novel Karachi-NF001 strain of brain-eating amoeba: Naegleria fowleri. Front. Mol. Biosci. https:\/\/doi.org\/10.3389\/fmolb.2023.1098217 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"51127_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00181-23","author":"M Guti\u00e9rrez-S\u00e1nchez","year":"2023","unstructured":"Guti\u00e9rrez-S\u00e1nchez, M., Carrasco-Y\u00e9pez, M. M., Correa-Basurto, J., Ram\u00edrez-Salinas, G. L. & Rojas-Hern\u00e1ndez, S. Two MP2CL5 antigen vaccines from Naegleria fowleri stimulate the immune response against meningitis in the BALB\/c model. Infect. Immun. https:\/\/doi.org\/10.1128\/iai.00181-23 (2023).","journal-title":"Infect. Immun."},{"key":"51127_CR17","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1007\/s00436-022-07660-y","volume":"121","author":"IB Rodr\u00edguez-Mera","year":"2022","unstructured":"Rodr\u00edguez-Mera, I. B. et al. Role of cathepsin B of Naegleria fowleri during primary amebic meningoencephalitis. Parasitol. Res. 121, 3287\u20133303. https:\/\/doi.org\/10.1007\/s00436-022-07660-y (2022).","journal-title":"Parasitol. Res."},{"key":"51127_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/elsc.201900151","volume":"20","author":"R Nitschel","year":"2020","unstructured":"Nitschel, R. et al. Engineering Pseudomonas putida KT2440 for the production of isobutanol. Eng. Life Sci. 20, 148\u2013159. https:\/\/doi.org\/10.1002\/elsc.201900151 (2020).","journal-title":"Eng. Life Sci."},{"key":"51127_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119093119","author":"MH Teplensky","year":"2022","unstructured":"Teplensky, M. H. et al. Spherical nucleic acids as an infectious disease vaccine platform. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.2119093119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"51127_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fimmu.2017.00278","volume":"8","author":"W Fleri","year":"2017","unstructured":"Fleri, W. et al. The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design. Front. Immunol. 8, 278 (2017).","journal-title":"Front. Immunol."},{"key":"51127_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-4","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-8-4 (2007).","journal-title":"BMC Bioinform."},{"key":"51127_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v.2\u2014a server for in silico prediction of allergens. J. Mol. Model. 20, 1\u20136. https:\/\/doi.org\/10.1007\/s00894-014-2278-5 (2014).","journal-title":"J. Mol. Model."},{"key":"51127_CR23","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. In silico approach for predicting toxicity of peptides and proteins. PLoS\u00a0One 8, e73957. https:\/\/doi.org\/10.1371\/journal.pone.0073957 (2013).","journal-title":"PLoS\u00a0One"},{"key":"51127_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/2629691","volume":"7","author":"A Mahram","year":"2015","unstructured":"Mahram, A. & Herbordt, M. C. NCBI BLASTP on high-performance reconfigurable computing systems. ACM Trans. Reconfig. Technol. Syst. 7, 1\u201320. https:\/\/doi.org\/10.1145\/2629691 (2015).","journal-title":"ACM Trans. Reconfig. Technol. Syst."},{"key":"51127_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/vaccines9040390","volume":"9","author":"F Kowalzik","year":"2021","unstructured":"Kowalzik, F. et al. mRNA-based vaccines. Vaccines 9, 390. https:\/\/doi.org\/10.3390\/vaccines9040390 (2021).","journal-title":"Vaccines"},{"key":"51127_CR26","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The Proteomics Protocols Handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger, E. et al. Protein analysis tools on the ExPASy server. In The Proteomics Protocols Handbook (ed. Walker, J. M.) (Humana Press, 2005). https:\/\/doi.org\/10.1385\/1-59259-890-0:571."},{"key":"51127_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","volume":"16","author":"LJ McGuffin","year":"2000","unstructured":"McGuffin, L. J., Bryson, K. & Jones, D. T. The PSIPRED protein structure prediction server. Bioinformatics 16, 404\u2013405. https:\/\/doi.org\/10.1093\/bioinformatics\/16.4.404 (2000).","journal-title":"Bioinformatics"},{"key":"51127_CR28","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","volume":"16","author":"Z Du","year":"2021","unstructured":"Du, Z. et al. The trRosetta server for fast and accurate protein structure prediction. Nat. Protoc. 16, 5634\u20135651. https:\/\/doi.org\/10.1038\/s41596-021-00628-9 (2021).","journal-title":"Nat. Protoc."},{"key":"51127_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2174\/092986607781483912","volume":"14","author":"K Gopalakrishnan","year":"2007","unstructured":"Gopalakrishnan, K., Sowmiya, G., Sheik, S. & Sekar, K. Ramachandran plot on the web (2.0). Protein Pept. Lett. 14, 669\u2013671. https:\/\/doi.org\/10.2174\/092986607781483912 (2007).","journal-title":"Protein Pept. Lett."},{"key":"51127_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov, D. et al. The ClusPro web server for protein\u2013protein docking. Nat. Protoc. 12, 255\u2013278. https:\/\/doi.org\/10.1038\/nprot.2016.169 (2017).","journal-title":"Nat. Protoc."},{"key":"51127_CR31","unstructured":"Castiglione, F.; Bernaschi, M. C-immsim: Playing with the immune response. In Proceedings of the Sixteenth International Symposium on Mathematical Theory of Networks and Systems. 2004, MTNS2004."},{"key":"51127_CR32","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote, A. et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 33, W526\u2013W531. https:\/\/doi.org\/10.1093\/nar\/gki376 (2005).","journal-title":"Nucleic Acids Res."},{"key":"51127_CR33","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco, J. R., Aliaga, J. I., Quintana-Ort\u00ed, E. S. & Chac\u00f3n, P. iMODS: Internal coordinates normal mode analysis server. Nucleic Acids Res. 42, W271\u2013W276. https:\/\/doi.org\/10.1093\/nar\/gku339 (2014).","journal-title":"Nucleic Acids Res."},{"key":"51127_CR34","unstructured":"CDC. General Information|Naegleria fowleri|CDC. www.cdc.gov. https:\/\/www.cdc.gov\/parasites\/naegleria\/general.html. Accessed 1 July 2023 (2022)."},{"key":"51127_CR35","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1128\/AAC.01293-15","volume":"59","author":"E Grace","year":"2015","unstructured":"Grace, E., Asbill, S. & Virga, K. Naegleria fowleri: Pathogenesis, diagnosis, and treatment options. Antimicrob. Agents Chemother. 59, 6677\u20136681 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"51127_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2017.02.007","volume":"49","author":"B Meza","year":"2017","unstructured":"Meza, B., Ascencio, F., Sierra-Beltr\u00e1n, A. P., Torres, J. & Angulo, C. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach. Infect. Genet. Evol. 49, 309\u2013317. https:\/\/doi.org\/10.1016\/j.meegid.2017.02.007 (2017).","journal-title":"Infect. Genet. Evol."},{"key":"51127_CR37","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/vaccines10050664","volume":"10","author":"M Naveed","year":"2022","unstructured":"Naveed, M. et al. A vaccine construction against COVID-19-associated mucormycosis contrived with immunoinformatics-based scavenging of potential mucoralean epitopes. Vaccines 10, 664. https:\/\/doi.org\/10.3390\/vaccines10050664 (2022).","journal-title":"Vaccines"},{"key":"51127_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1850357","author":"VS Ayyagari","year":"2020","unstructured":"Ayyagari, V. S., Venkateswarulu, T. C., Peele, K. A. & Krupanidhi, S. Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: An immunoinformatics approach. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1850357 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"51127_CR39","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jiph.2021.04.010","volume":"14","author":"M Naveed","year":"2021","unstructured":"Naveed, M. et al. Design of a novel multiple epitope-based vaccine: An immunoinformatics approach to combat SARS-CoV-2 strains. J. Infect. Public Health 14, 938\u2013946. https:\/\/doi.org\/10.1016\/j.jiph.2021.04.010 (2021).","journal-title":"J. Infect. Public Health"},{"key":"51127_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jgid.jgid_96_21","volume":"14","author":"S Kitambi","year":"2022","unstructured":"Kitambi, S. et al. Epitope identification and designing a potent multi-epitope vaccine construct against SARS-CoV-2 including the emerging variants. J. Glob. Infect. Dis. 14, 24. https:\/\/doi.org\/10.4103\/jgid.jgid_96_21 (2022).","journal-title":"J. Glob. Infect. Dis."},{"key":"51127_CR41","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.drudis.2020.03.006","volume":"25","author":"S Parvizpour","year":"2020","unstructured":"Parvizpour, S., Pourseif, M. M., Razmara, J., Rafi, M. A. & Omidi, Y. Epitope-based vaccine design: A comprehensive overview of bioinformatics approaches. Drug Discov. Today 25, 1034\u20131042. https:\/\/doi.org\/10.1016\/j.drudis.2020.03.006 (2020).","journal-title":"Drug Discov. Today"},{"key":"51127_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93266-w","author":"R Sharma","year":"2021","unstructured":"Sharma, R., Rajput, V. S., Jamal, S., Grover, A. & Grover, S. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-021-93266-w (2021).","journal-title":"Sci. Rep."},{"key":"51127_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.960285","author":"M Naveed","year":"2022","unstructured":"Naveed, M. et al. Evaluation of the whole proteome to design a novel mRNA-based vaccine against multidrug-resistant Serratia marcescens. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.960285 (2022).","journal-title":"Front. Microbiol."},{"key":"51127_CR44","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/eji.201445329","volume":"45","author":"HG Choi","year":"2015","unstructured":"Choi, H. G. et al. Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells. Eur. J. Immunol. 45, 1957\u20131971. https:\/\/doi.org\/10.1002\/eji.201445329 (2015).","journal-title":"Eur. J. Immunol."},{"key":"51127_CR45","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3390\/pharmaceutics14081671","volume":"14","author":"DA Diaz-Dinamarca","year":"2022","unstructured":"Diaz-Dinamarca, D. A. et al. Protein-based adjuvants for vaccines as immunomodulators of the innate and adaptive immune response: Current knowledge, challenges, and future opportunities. Pharmaceutics 14, 1671\u20131671. https:\/\/doi.org\/10.3390\/pharmaceutics14081671 (2022).","journal-title":"Pharmaceutics"},{"key":"51127_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01144","author":"S Kumar","year":"2019","unstructured":"Kumar, S., Sunagar, R. & Gosselin, E. Bacterial protein toll-like-receptor agonists: A novel perspective on vaccine adjuvants. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01144 (2019).","journal-title":"Front. Immunol."},{"key":"51127_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/b978-0-323-91172-6.00007-8","volume-title":"Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 infection","author":"P Subhaswaraj","year":"2022","unstructured":"Subhaswaraj, P. & Siddhardha, B. Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2. In Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 infection 1st edn (eds Parihar, A. et al.) 207\u2013246 (Elsevier, 2022). https:\/\/doi.org\/10.1016\/b978-0-323-91172-6.00007-8.","edition":"1"},{"key":"51127_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.18388\/abp.2020_6696","volume":"70","author":"M Naveed","year":"2023","unstructured":"Naveed, M. et al. A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1. Acta Biochim. Pol. 70, 407\u2013418. https:\/\/doi.org\/10.18388\/abp.2020_6696 (2023).","journal-title":"Acta Biochim. Pol."},{"key":"51127_CR49","doi-asserted-by":"publisher","first-page":"e0253393","DOI":"10.1371\/journal.pone.0253393","volume":"16","author":"MT Khan","year":"2021","unstructured":"Khan, M. T. et al. Immunoinformatics and molecular dynamics approaches: Next generation vaccine design against West Nile virus. PLoS\u00a0One 16, e0253393. https:\/\/doi.org\/10.1371\/journal.pone.0253393 (2021).","journal-title":"PLoS\u00a0One"},{"key":"51127_CR50","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin, N., Lund, O., Bernaschi, M. & Castiglione, F. Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PLoS\u00a0One 5, e9862. https:\/\/doi.org\/10.1371\/journal.pone.0009862 (2010).","journal-title":"PLoS\u00a0One"},{"key":"51127_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-022-00511-y","volume":"7","author":"MS Gebre","year":"2022","unstructured":"Gebre, M. S. et al. mRNA vaccines induce rapid antibody responses in mice. NPJ Vaccines 7, 1. https:\/\/doi.org\/10.1038\/s41541-022-00511-y (2022).","journal-title":"NPJ Vaccines"},{"key":"51127_CR52","doi-asserted-by":"publisher","first-page":"eabc9396","DOI":"10.1126\/scitranslmed.abc9396","volume":"12","author":"JH Erasmus","year":"2020","unstructured":"Erasmus, J. H. et al. An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Sci. Transl. Med. 12, eabc9396. https:\/\/doi.org\/10.1126\/scitranslmed.abc9396 (2020).","journal-title":"Sci. Transl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-51127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-51127-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-51127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T11:27:14Z","timestamp":1704713234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-51127-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51127"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-51127-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"assertion":[{"value":"21 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"767"}}